首页> 美国卫生研究院文献>BioMed Research International >Study of Antiobesity Effect through Inhibition of Pancreatic Lipase Activity of Diospyros kaki Fruit and Citrus unshiu Peel
【2h】

Study of Antiobesity Effect through Inhibition of Pancreatic Lipase Activity of Diospyros kaki Fruit and Citrus unshiu Peel

机译:抑制柿柿和柑桔皮胰脂肪酶活性的抗肥胖作用研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pancreatic lipase is the enzyme responsible for digestion and absorption of triglycerides, being its inhibition one of the widest studied methods used to determine the potential activity of natural products to inhibit dietary fat absorption. Decrease of energy intake from dietary fat through inhibition of this enzyme may be an excellent strategy to prevent and treat obesity. The inhibitory activity on pancreatic lipase enzyme of Diospyros kaki fruit and Citrus unshiu peel mixture extract (PCM) was evaluated in vitro and its antiobesity effects were studied based on the serum lipid parameters analysis from high-fat diet- (HFD-) fed mice in vivo. PCM was orally administered at a dose of 50 and 200 mg/kg body weight for 6 weeks. In addition, the activity of pancreatic lipase was assessed using orlistat (positive control). PCM exhibited inhibitory effect on lipase activity with IC50 value of 507.01 μg/mL. Moreover, serum triacylglycerol, total cholesterol levels, and visceral fat weight were significantly reduced compared to HFD control mice in PCM 200 mg/kg-treated mice (p < 0.05). These results suggest that PCM administration may be a novel potential antiobesity agent for reduction of fat absorption via inhibition of pancreatic lipase.
机译:胰腺脂肪酶是负责甘油三酸酯消化和吸收的酶,是其抑制作用之一,是确定天然产物抑制膳食脂肪吸收潜力的最广泛研究方法之一。通过抑制这种酶来减少饮食中脂肪的能量摄入可能是预防和治疗肥胖的极佳策略。在体外评价高脂饮食(HFD-)喂养小鼠的血脂参数,研究了柿(Diospyros kaki)果实和柑桔皮混合物提取物(PCM)对胰腺脂肪酶的抑制活性,并研究了其抗肥胖作用。体内。 PCM以50和200μmg/ kg体重的剂量口服6周。另外,使用奥利司他(阳性对照)评估胰腺脂肪酶的活性。 PCM对脂肪酶活性具有抑制作用,IC50值为507.01μg/ mL。此外,与PCM 200μmg/ kg处理的小鼠的HFD对照小鼠相比,血清三酰甘油,总胆固醇水平和内脏脂肪重量显着降低(p <0.05)。这些结果表明,PCM给药可能是通过抑制胰腺脂肪酶减少脂肪吸收的新型潜在抗肥胖药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号